Success Story: EB-1B Approval in 20 Days for a Biochemistry Researcher Advancing Human Disease Studies
Client’s Testimonial:
"I am extremely pleased with the services provided by Chen Immigration Law Associates for my EB-1B petition. Their team demonstrated exceptional expertise in preparing a strong and well-organized case, from developing the petition strategy to refining recommendation letters and supporting evidence. They were professional, responsive, and thorough throughout the process. Thanks to their outstanding work, my EB-1B petition was approved under Premium Processing with no Request for Evidence (RFE). I highly recommend Chen Immigration to researchers and academics seeking immigration counsel.”
On June 4th, 2026, we received another EB-1B (Outstanding Professors and Researchers) approval for an Instructor in the Field of Biochemistry (Approval Notice).
General Field: Biochemistry
Position at the Time of Case Filing: Instructor
Country of Origin: India
State of Residence at the Time of Filing: New York
Approval Notice Date: June 4th, 2026
Processing Time: 20 days (Premium Processing Requested)
Case Summary:
We are pleased to share that the client’s I-140 EB-1B petition was approved in just 20 days after being filed directly with premium processing. The client, who holds a Ph.D. in chemistry, is a biochemistry researcher whose work has advanced scientific understanding across three important areas of human disease research, including the genetic basis of autism spectrum disorder, cancer progression, and cellular stress adaptation.
The client is currently employed as an instructor, where the client conducts independent and collaborative research involving the biochemical and genetic characterization of RNA polymerase II-mediated transcription in yeast and human cells. This work focuses especially on transcriptional misregulation in cancer and supports broader efforts to understand gene expression, cellular health, and disease prevention.
In preparing the petition, we emphasized that the client’s significance could be shown through both the substance of the research and the way the field had responded to it. The client’s record included 4 peer-reviewed journal articles, including 1 first-authored and 1 co-first-authored article, 3 first-authored conference abstracts, and 1 first-authored book chapter. These works had received 96 citations, showing that other researchers had relied on the client’s findings in later studies involving neurodevelopmental disorders, cancer biology, epigenetics, redox metabolism, and cellular survival mechanisms. The client had also completed at least 27 peer reviews, which helped demonstrate that journals trusted the client’s technical judgment and recognized the client as qualified to evaluate research in the same or allied fields.
Rather than treating these achievements as numbers alone, the petition explained how they reflected international recognition and outstanding research ability. The citation record showed independent reliance on the client’s findings, while the peer-review record demonstrated sustained trust from the scientific community. We also highlighted the client’s contributions to research supported by major funding sources, which further supported the importance of the research areas involved.
The case was also supported by 4 recommendation letters from experts in the field, including independent experts who were familiar with the client’s work through its published impact. These letters helped connect the objective evidence to the broader significance of the client’s research and confirmed that the client’s work had influenced the field beyond the client’s own laboratory.
“Ensuring the continuation of Dr. Bandyopadhyay’s work is essential to both biochemistry research and to the national interest.”
By presenting the client’s publication record, citation impact, peer-review service, funded research background, current employment, and original contributions as a cohesive record of international recognition, we demonstrated that the client qualified as an outstanding researcher in biochemistry.
We congratulate the client on this I-140 EB-1B approval and wish the client continued success in advancing biomedical research in the United States.